Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulation
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 113 (6) , 371-378
- https://doi.org/10.1016/j.thromres.2004.04.004
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Human Parvovirus B19Clinical Microbiology Reviews, 2002
- Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patientsBritish Journal of Haematology, 2002
- Manufacturing of a Prothrombin Complex Concentrate Aiming at Low ThrombogenicityThrombosis Research, 2000
- Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergenciesBritish Journal Of Neurosurgery, 2000
- Human Parvovirus B19: Prevalence of Viral DNA in Volunteer Blood Donors and Clinical Outcomes of Transfusion RecipientsVox Sanguinis, 1998
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Bleeding complications in oral anticoagulant therapy. An analysis of risk factorsArchives of internal medicine (1960), 1993
- Emergency reversal of anticoagulation after intracerebral hemorrhage.Stroke, 1992
- Transmission of Human Parvovirus B19 by Coagulation Factor ConcentratesVox Sanguinis, 1990
- Comparison of prothrombin complex concentrate and vitamin K1 in oral anticoagulant reversal.BMJ, 1976